https://www.selleckchem.com/pr....oducts/bemnifosbuvir
An amendment to this paper has been published and can be accessed via a link at the top of the paper.Androgen receptor (AR) signaling is a major driver of prostate cancer (CaP). Although most therapies targeting AR are initially effective in CaP patients, drug resistance is inevitable, mainly because of the inappropriate re-activation of AR pathway. However, the underlying mechanisms remain largely unknown. Here, we found that phospholipase C epsilon (PLCɛ) was highly expressed in CaP samples, and was closely as
Like
Comment
Share
